Sam Eiber
Stock Analyst at BTIG
(0.64)
# 4,357
Out of 5,182 analysts
15
Total ratings
23.08%
Success rate
-10.94%
Average return
Main Sectors:
Stocks Rated by Sam Eiber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APYX Apyx Medical | Upgrades: Buy | $6 | $3.67 | +63.49% | 2 | Mar 11, 2026 | |
| SBC SBC Medical Group Holdings | Initiates: Buy | $8 | $3.38 | +136.69% | 1 | Mar 6, 2026 | |
| EOLS Evolus | Reiterates: Buy | $13 | $5.27 | +146.68% | 5 | Mar 4, 2026 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $86 → $88 | $64.40 | +36.65% | 4 | Feb 24, 2026 | |
| MMSI Merit Medical Systems | Initiates: Buy | $107 | $66.74 | +60.32% | 1 | Feb 6, 2026 | |
| INMD InMode | Downgrades: Neutral | n/a | $14.21 | - | 2 | Apr 29, 2025 |
Apyx Medical
Mar 11, 2026
Upgrades: Buy
Price Target: $6
Current: $3.67
Upside: +63.49%
SBC Medical Group Holdings
Mar 6, 2026
Initiates: Buy
Price Target: $8
Current: $3.38
Upside: +136.69%
Evolus
Mar 4, 2026
Reiterates: Buy
Price Target: $13
Current: $5.27
Upside: +146.68%
Establishment Labs Holdings
Feb 24, 2026
Maintains: Buy
Price Target: $86 → $88
Current: $64.40
Upside: +36.65%
Merit Medical Systems
Feb 6, 2026
Initiates: Buy
Price Target: $107
Current: $66.74
Upside: +60.32%
InMode
Apr 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $14.21
Upside: -